Health in Chad 1,172 indicators covering health for Chad. IndicatorLatest Year10-yr change Rank Death rate from ischaemic heart disease who ghe age standardized 85.08 2021 down 9.4% 114th Deaths from cardiovascular disease type 283.61 2021 up 5.5% 57th Death rate from rheumatic heart disease who ghe age standardized 3.46 2021 down 22.2% 37th Tuberculosis death rate age standardized 64.09 2021 down 3.1% 35th Burden of disease who 68,801 2021 down 23.6% 5th Total disease burden who 11.82 million 2021 up 6.6% 48th Rate of disease burden from drug use disorders who 30.25 2021 down 0.9% 192nd Prevalence of moderate or severe food insecurity in the population 66.3% 2023 down 2.4% 13th Male female ratio suicides rates 2.41 2021 down 1.5% 145th Number of people notified with new episode of TB in a given year 14,091 2021 up 30.8% 45th Number of people diagnosed with new episode of pulmonary TB who are cl 4,143 2021 down 1.6% 38th Number of people diagnosed with new episode of pulmonary TB who have e 1,532 2021 up 48.3% 58th Antiretroviral therapy coverage for PMTCT 77.0% 2024 up 8.5% 46th Share of men who are smoking 13.5 2022 down 15.1% 152nd Comparing the share of men and women who are smoking 13.5 2022 down 15.1% 152nd Share of women who are smoking 1.9 2022 down 20.8% 136th Adults smoking 2007 2018 7.7 2022 down 15.4% 156th Cases started on MDR-TB treatment 118 2024 up 883.3% 68th Prevalence of severe food insecurity in the population 25.2% 2023 down 22.2% 12th Share healthy diet unaffordable 64.1 2024 down 0.2% 21st Number of people diagnosed with new episode of pulmonary TB who are ba 7,968 2021 up 79.7% 45th Raised fasting blood glucose (>=7.0 mmol/L) 7 2014 up 32.1% 139th Mean fasting blood glucose (mmol/l) 5.25 2014 up 2.1% 106th Raised fasting blood glucose (>= 7.0 mmol/L) 4.6 2014 up 27.8% 172nd Reported number of people requiring interventions against NTDs 6.17 million 2024 down 41.1% 37th Child deaths from streptococcus by disease 313 2015 up 4.7% 13th Births attended by skilled health personnel 47.2% 2019 up 177.6% 159th Percentage of total deaths due to NCDs overall and percentage of total 67.88 2019 down 7.4% 1st Number of new leprosy cases 282 2024 up 9.3% 26th Pharmacists 0.08 2024 up 33.3% 157th Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 68.0% 2025 up 142.9% 178th Number of new hivaids infections who 4,300 2024 down 30.6% 36th Number of current cigarette smokers, estimate 589,000 2030 up 27.5% 94th Incidence of malaria 206.14 per 1,000 population at risk 2024 down 2.8% 24th Reported number of children receiving antiretroviral therapy 3,008 2025 up 96.3% 27th Concentrations of fine particulate matter 59.43 2023 up 12.7% 2nd Death rate road traffic injuries 32.4 2019 up 31.2% 16th New or unknown treatment history cases: Pulmonary, bacteriologically c 10,119 2023 up 112.7% 42nd Cholera case fatality rate 4.3 2019 down 52.0% 10th Medical doctors not further defined 15 2019 down 95.9% 141st Life satisfaction vs life expectancy 55.07 2023 up 7.9% 235th Estimate of current cigarette smoking prevalence 4.6% 2030 down 11.5% 144th Estimate of current cigarette smoking prevalence (%) 4.9% 2030 down 12.5% 144th Tb patients tested positive for hiv 1,555 2021 up 62.1% 32nd Number of children aged 6-59 months with anaemia 1,905 2019 up 11.6% 30th Prevalence of anaemia in children aged 6-59 months 66.3% 2019 down 12.1% 16th Number of deaths attributed to non-communicable diseases, by type of d 5,792 2019 up 38.9% 115th Hepatitis B surface antigen (HBsAg) prevalence 2.2% 2024 down 56.9% 11th Mean hemoglobin level of children aged 6-59 months 102 2019 up 4.1% 180th Estimated number of MDR/RR-TB incident cases 400 2024 down 21.6% 66th Mortality caused by road traffic injury 32.4 per 100,000 population 2019 up 30.1% 16th Mortality caused by road traffic injury, female 21.6 per 100,000 female population 2019 up 26.3% 6th Mortality caused by road traffic injury, male 43.3 per 100,000 male population 2019 up 32.0% 25th Ipv vaccine coverage 67 2024 up 139.3% 178th Tb patients living with hiv receiving art 1,543 2021 up 278.2% 30th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 78.6% 1st Treatment success rate for patients treated for MDR-TB 73.0% 2022 up 30.4% 83rd New leprosy case detection rate per 1 000 000 population 13.89 2024 down 28.9% 36th Treatment success rate: HIV-positive TB cases 81 2023 up 2.5% 51st Prevalence of wasting, weight for height 7.8% 2022 down 52.1% 21st ← Previous Page 14 of 20 Next →